NDA 201890 describes EZETIMIBE AND SIMVASTATIN, which is a drug marketed by
Alkem Labs Ltd,
Amneal Pharms Co,
Ani Pharms,
Aurobindo Pharma Usa,
Dr Reddys Labs Sa,
Glenmark Pharms Ltd, and
Watson Labs Inc, and is included in seven NDAs. It is available from
twelve suppliers. Additional details are available on the
EZETIMIBE AND SIMVASTATIN profile page.
The generic ingredient in EZETIMIBE AND SIMVASTATIN is
ezetimibe; simvastatin. There are twenty-four
drug master file entries for this compound. Thirteen
suppliers are listed for this compound. Additional details are available on the
ezetimibe; simvastatin profile page.